AIIMS, Bhubaneshwar

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes2 trials
• Childhood cancers1 trial
• Lung cancer1 trial
• Obesity1 trial
• Systemic sclerosis (scleroderma)1 trial
• Thyroid cancer1 trial

Phase

• Phase 32 trials
• Phase 42 trials

Status

• Not yet recruiting3 trials
• Active, not recruiting1 trial

Lead sponsor

• Boehringer Ingelheim2 trials
• Eli Lilly and Company2 trials

Running trials

• Not yet recruiting

  A Study of Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in India

  NCT07822880· Phase 4· Eli Lilly and Company· Source

  Contact: Sourav Mishra (principal investigator)

• Recruiting

  A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  NCT07754461· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

  NCT07438444· Phase 4· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Lung cancer1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Thyroid cancer1 recruiting
• Type 2 diabetes1 recruiting